Skip to Content

112 (Januvia 50 mg)

Generic Name: sitagliptin

Pill with imprint 112 is Beige, Round and has been identified as Januvia 50 mg. It is supplied by Merck & Company Inc..

Januvia is used in the treatment of diabetes, type 2 and belongs to the drug class dipeptidyl peptidase 4 inhibitors. There is no proven risk in humans during pregnancy. Januvia 50 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for 112

Januvia 50 mg 112
Januvia 50 mg 112  Front
Januvia 50 mg 112  Back
Januvia 50 mg 112

Januvia

Generic Name:
sitagliptin
Imprint:
112
Strength:
50 mg
Color:
Beige
Size:
8.00 mm
Shape:
Round
Availability:
Prescription only
Drug Class:
Dipeptidyl peptidase 4 inhibitors
Pregnancy Category:
B - No proven risk in humans
CSA Schedule:
Not a controlled drug
Labeler / Supplier:
Merck & Company Inc.
Inactive Ingredients:
calcium phosphate dibasic anhydrous
croscarmellose sodium
magnesium stearate
microcrystalline cellulose
polyethylene glycol
polyvinyl alcohol
ferric oxide red
sodium stearyl fumarate
magnesium silicate
titanium dioxide
ferric oxide yellow
Note: Inactive ingredients may vary.

Other Labelers / Repackagers:

NDC CodeLabeler / Repackager
54868-6031 Physicians Total Care Inc. (repackager)

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide